These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28000565)
1. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma. Cheng J; Zheng G; Jin H; Gao X Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565 [TBL] [Abstract][Full Text] [Related]
2. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma. Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863 [TBL] [Abstract][Full Text] [Related]
3. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging. Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730 [TBL] [Abstract][Full Text] [Related]
4. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas. Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075 [TBL] [Abstract][Full Text] [Related]
5. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform. Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477 [TBL] [Abstract][Full Text] [Related]
6. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma. Cheng J; Liu Q; Jin H; Zeng D; Liao Y; Zhao Y; Gao X; Zheng G Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165966. PubMed ID: 32931889 [TBL] [Abstract][Full Text] [Related]
7. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers. Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110 [TBL] [Abstract][Full Text] [Related]
8. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma. Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715 [TBL] [Abstract][Full Text] [Related]
9. Untargeted metabolomics analysis of esophageal squamous cell cancer progression. Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685 [TBL] [Abstract][Full Text] [Related]
10. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma. Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382 [TBL] [Abstract][Full Text] [Related]
11. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma. Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700 [TBL] [Abstract][Full Text] [Related]
12. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466 [TBL] [Abstract][Full Text] [Related]
13. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform. Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma. Fendereski M; Zia MF; Shafiee M; Safari F; Saneie MH; Tavassoli M Cancer Invest; 2017 Feb; 35(2):78-84. PubMed ID: 28095062 [TBL] [Abstract][Full Text] [Related]
15. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832 [TBL] [Abstract][Full Text] [Related]
16. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. Cui Y; Xue Y; Dong S; Zhang P J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538 [TBL] [Abstract][Full Text] [Related]
17. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study. Fan NJ; Gao CF; Wang XL OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma. Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617 [TBL] [Abstract][Full Text] [Related]
19. Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry. Xu J; Li J; Zhang R; He J; Chen Y; Bi N; Song Y; Wang L; Zhan Q; Abliz Z Talanta; 2019 Jan; 192():160-168. PubMed ID: 30348373 [TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]